Related Experiment Video

Updated: May 2, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K

Using genetic variation for establishing causality of cardiovascular risk factors: overcoming confounding and reverse

R A J Smit1, S Trompet, A J M de Craen

  • 1Department of Gerontology and Geriatrics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands, r.a.j.smit@lumc.nl.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|March 5, 2014
PubMed

Insights

Cardiovascular disease (CVD) research faces challenges from confounding and reverse causation. Mendelian randomization using genetic variation offers a promising approach to reliably identify causal risk factors for CVD.

Area of Science:

  • Epidemiology
  • Genetics
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease (CVD) is a leading cause of death globally.
  • Observational studies have identified numerous CVD risk factors, but findings are sometimes inconsistent.
  • Confounding and reverse causation can limit the validity of traditional epidemiological research.

Purpose of the Study:

  • To explore the potential of genetic epidemiology, specifically Mendelian randomization, in establishing causal relationships for cardiovascular risk factors.
  • To discuss the advantages and limitations of using genetic variation to overcome challenges in CVD research.

Main Methods:

  • Utilizing Mendelian randomization, a genetic epidemiology technique.
  • Analyzing genetic variations as instrumental variables for risk factors.
  • Comparing findings with traditional observational study designs.

Main Results:

  • Mendelian randomization can help distinguish true causal effects from confounding and reverse causation.
  • Genetic approaches offer a robust method for causal inference in cardiovascular research.
  • Limitations exist, including the need for specific genetic variants and potential for pleiotropy.

Conclusions:

  • Genetic epidemiology, particularly Mendelian randomization, holds significant promise for advancing our understanding of CVD.
  • This method provides a powerful tool to establish causality of cardiovascular risk factors, overcoming limitations of conventional studies.
  • Further research is needed to fully leverage the potential and address the limitations of genetic approaches in CVD etiology.

More Related Videos

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

2.0K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.1K

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
596
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
1.1K
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
2.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138